News

The Berlin startup Lucid Genomics, a spin-off of the Max Planck Institute for Molecular Genetics and Charité - Universitätsmedizin Berlin, uses AI-based tools to decode previously undiscovered parts of human DNA. Founders Uirá Souto Melo and Hossein Moeinzadeh have now received 1.3 million euros in pre-seed funding to further develop their…

At a festive award ceremony on 26 June 2024 at Berliner Sparkasse in Wannsee, UniWearables UG by Raphael Lang and Maximilian Blendinger was awarded 2nd place in the "Science & Startups" prize of Berliner Sparkasse. UniWearables, supported by Charité BIH Innovation (CBI), the joint technology transfer of Charité and Berlin Institute of Health (BIH),…

The signing of a Memorandum of Understanding (MoU) between Charité - Universitätsmedizin Berlin, the Berlin Institute of Health (BIH) and Enterprise Singapore (ESG) has laid the foundation for a professional network of startups from Singapore and renowned scientists from Charité and BIH to promote joint research and transfer projects, which…

The BoneGuide team is one step closer to making its transformative bone healing technology available to healthcare providers and patients alike. BoneGuide is a project of Charité - Universitätsmedizin Berlin and is supported by Charité BIH Innovation. On May 1, 2024, Aaron Herrera and his team officially entered the first phase of the EXIST…

On April 9, 2024, the BIH Charité Advanced Clinician Scientist Pilot Program (AdCSP) was successfully evaluated by a top-class external panel of experts and can now enter the second funding phase of three years.

Charité/BIH and Enterprise Singapore (ESG) have established an innovation support program that promotes cooperation between excellent clinicians from Charité/BIH and start-ups from Singapore. Following the successful application of start-ups from Singapore, we are now looking for project partners at Charité/BIH.

On 28 February 2024, the team from Charité BIH Innovation (CBI) - the joint technology transfer of Charité - Universitätsmedizin Berlin and the Berlin Institute of Health (BIH) - was delighted to receive a visit from Prof. Heyo. K. Kroemer, Chairman of the Executive Board of Charité, Prof. Dr Joachim Spranger, Dean of Charité, Prof. Dr Christopher…

Single-cell RNA sequencing (scRNA-seq) has expanded our ability to distinguish cell populations and elucidate their interactions with each other. However, there are still difficulties in distinguishing leukemia cells from normal hematopoiesis based on gene expression alone. Livius Penter, BIH Digital Clinician Scientist Fellow and specialist at the…